Literature DB >> 24005802

Signalling: Seeing the big picture.

Sarah Seton-Rogers.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24005802     DOI： 10.1038/nrc3602

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  2 in total

1.  Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer.

Authors:  Lidia Bosurgi; Jochem H Bernink; Victor Delgado Cuevas; Nicola Gagliani; Leonel Joannas; Edward T Schmid; Carmen J Booth; Sourav Ghosh; Carla V Rothlin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

2.  The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells.

Authors:  Aaron S Meyer; Miles A Miller; Frank B Gertler; Douglas A Lauffenburger
Journal:  Sci Signal       Date:  2013-08-06       Impact factor: 8.192
  2 in total
  1 in total

1.  Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.

Authors:  Julia Onken; Robert Torka; Sören Korsing; Josefine Radke; Irina Krementeskaia; Melina Nieminen; Xi Bai; Axel Ullrich; Frank Heppner; Peter Vajkoczy
Journal:  Oncotarget       Date:  2016-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.